Clinical Trial Update: Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors [NA]

View source ↗

Summary

Grit Biotechnology is conducting a clinical trial to assess GT201 in combination with a PD-1 inhibitor for advanced head and neck squamous cell carcinoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• GT201
• PD-1 inhibitor

Snippet

Sponsor: Grit Biotechnology | Conditions: HNSCC | NA | Status: RECRUITING